Clinical trial
Efficacy of Topical Latanoprost 0.005% Verses Timolol 0.5% Demonstrated by Corneal Biomechanical Correcting Modified Goldmann Prism
NCT04178863 is registered in ClinicalTrials.gov with Intuor Technologies, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Topical Latanoprost 0.005% Verses Timolol 0.5% Demonstrated by Corneal Biomechanical Correcting Modified Goldmann Prism
- Lead sponsor
- Intuor Technologies, Inc.
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- July 1, 2018
- Completion date
- December 30, 2019
- Enrollment
- 72 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
glaucoma; drugs